NOREPINEPHRINE

N/A

Manufactured by Professional Complementary Health Formulas

24,944 FDA adverse event reports analyzed

Last updated: 2026-04-14

About NOREPINEPHRINE

NOREPINEPHRINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Professional Complementary Health Formulas. The most commonly reported adverse reactions for NOREPINEPHRINE include DRUG INEFFECTIVE, OFF LABEL USE, HYPOTENSION, ACUTE KIDNEY INJURY, MULTIPLE ORGAN DYSFUNCTION SYNDROME. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for NOREPINEPHRINE.

Top Adverse Reactions

DRUG INEFFECTIVE2,373 reports
OFF LABEL USE1,101 reports
HYPOTENSION1,011 reports
ACUTE KIDNEY INJURY747 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME652 reports
TOXICITY TO VARIOUS AGENTS624 reports
CONDITION AGGRAVATED560 reports
SEPSIS537 reports
CARDIAC ARREST533 reports
CARDIOGENIC SHOCK503 reports
SEPTIC SHOCK438 reports
RESPIRATORY FAILURE375 reports
SHOCK374 reports
METABOLIC ACIDOSIS346 reports
INTENTIONAL OVERDOSE327 reports
DRUG INTERACTION325 reports
VOMITING325 reports
PRODUCT USE IN UNAPPROVED INDICATION324 reports
PNEUMONIA316 reports
DEATH312 reports
LACTIC ACIDOSIS309 reports
BRADYCARDIA308 reports
OVERDOSE289 reports
ABDOMINAL PAIN288 reports
NAUSEA287 reports
TACHYCARDIA285 reports
GENERAL PHYSICAL HEALTH DETERIORATION264 reports
HYPONATRAEMIA264 reports
PYREXIA248 reports
RENAL FAILURE247 reports
ASCITES239 reports
VENTRICULAR FIBRILLATION238 reports
ABDOMINAL DISTENSION234 reports
THROMBOCYTOPENIA231 reports
ACUTE RESPIRATORY DISTRESS SYNDROME228 reports
DYSPNOEA228 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION224 reports
CONSTIPATION218 reports
ANAEMIA217 reports
COMA215 reports
APPENDICITIS211 reports
APPENDICOLITH206 reports
SOMNOLENCE205 reports
HYPOXIA194 reports
ELECTROCARDIOGRAM QT PROLONGED193 reports
STRESS193 reports
RHABDOMYOLYSIS181 reports
HAEMODYNAMIC INSTABILITY175 reports
PULMONARY EMBOLISM167 reports
RENAL IMPAIRMENT163 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS162 reports
FOETAL EXPOSURE DURING PREGNANCY160 reports
TOXIC EPIDERMAL NECROLYSIS151 reports
HYPERTENSION150 reports
BLOOD CREATININE INCREASED146 reports
VENTRICULAR TACHYCARDIA146 reports
ALANINE AMINOTRANSFERASE INCREASED144 reports
PULMONARY OEDEMA144 reports
SEROTONIN SYNDROME143 reports
BLOOD PRESSURE DECREASED138 reports
DRUG HYPERSENSITIVITY138 reports
INTENTIONAL PRODUCT MISUSE138 reports
HYPERKALAEMIA136 reports
MATERNAL EXPOSURE DURING PREGNANCY134 reports
BLOOD PHOSPHORUS INCREASED133 reports
SEIZURE132 reports
ASPARTATE AMINOTRANSFERASE INCREASED127 reports
ATRIAL FIBRILLATION124 reports
PREMATURE BABY124 reports
THERAPY NON RESPONDER123 reports
CIRCULATORY COLLAPSE121 reports
DRY MOUTH121 reports
DEPRESSED LEVEL OF CONSCIOUSNESS119 reports
THROMBOSIS118 reports
PLEURAL EFFUSION117 reports
VASOPLEGIA SYNDROME114 reports
SUICIDE ATTEMPT112 reports
CARDIO RESPIRATORY ARREST110 reports
DIABETES MELLITUS106 reports
DIARRHOEA106 reports
INCORRECT ROUTE OF PRODUCT ADMINISTRATION105 reports
BLOOD CHOLESTEROL INCREASED104 reports
ACUTE RESPIRATORY FAILURE103 reports
BACTERIAL INFECTION103 reports
CARDIAC FAILURE103 reports
EXPOSURE DURING PREGNANCY102 reports
STRESS CARDIOMYOPATHY102 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE99 reports
MYASTHENIA GRAVIS99 reports
ACIDOSIS98 reports
COAGULOPATHY98 reports
DISSEMINATED INTRAVASCULAR COAGULATION97 reports
TROPONIN INCREASED97 reports
SWELLING96 reports
DRUG INTOLERANCE93 reports
BLOOD URIC ACID INCREASED92 reports
PLATELET COUNT DECREASED92 reports
FEBRILE NEUTROPENIA91 reports
HYPERLACTACIDAEMIA91 reports
HYPOPHOSPHATAEMIA90 reports

Report Outcomes

Out of 10,231 classified reports for NOREPINEPHRINE:

Serious 96.8%Non-Serious 3.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male5,189 (55.3%)
Female4,176 (44.5%)
Unknown15 (0.2%)

Reports by Age

Age 80310 reports
Age 68254 reports
Age 67231 reports
Age 60205 reports
Age 62187 reports
Age 61184 reports
Age 53183 reports
Age 74183 reports
Age 65182 reports
Age 64178 reports
Age 59177 reports
Age 49167 reports
Age 55167 reports
Age 66166 reports
Age 57164 reports
Age 69162 reports
Age 75161 reports
Age 71160 reports
Age 72159 reports
Age 54157 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with NOREPINEPHRINE?

This profile reflects 24,944 FDA FAERS reports that mention NOREPINEPHRINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for NOREPINEPHRINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, HYPOTENSION, ACUTE KIDNEY INJURY, MULTIPLE ORGAN DYSFUNCTION SYNDROME, TOXICITY TO VARIOUS AGENTS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures NOREPINEPHRINE?

Labeling and FAERS entries often list Professional Complementary Health Formulas in connection with NOREPINEPHRINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.